Overview

A Study Of SU011248 Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel In Patients With Advanced Breast Cancer

Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
To compare treatment with SU011248 plus paclitaxel versus bevacizumab plus paclitaxel to determine which treatment works better against breast cancer
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Albumin-Bound Paclitaxel
Bevacizumab
Paclitaxel
Sunitinib